Search Browse Earnings

Applied Therapeutics, Inc. — SlamSEC

Applied Therapeutics, Inc.

Nasdaq:APLT

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$10.0M

+0.0% YoY

FY 2024

Adj. EBITDA

—

Net Income

-$119.8M

-1198.5% margin

FY 2024

EPS (Diluted)

-$1.42

FY 2024

Stock Price

$0.10

+0.2%

2026-02-02

52W Range

$0.09 – $1.50

P/E Ratio

-0.1x

Market Cap

$14.9M

Cash

$49.9M

FY 2024

Total Debt

—

Net Cash

$49.9M

FY 2024

Enterprise Value

-$35.0M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—